gene
express
silenc
target
destruct
specif
mrna
molecul
highli
conserv
process
known
rna
interfer
rnai
short
interf
rna
sirna
function
directli
cytoplasm
assembl
silenc
complex
risc
compris
sever
protein
sirna
figur
complex
activ
atp
sirna
becom
singl
strand
complex
abl
bind
complementari
complementari
mrna
sequenc
found
nucleas
activ
risc
destroy
lieu
deliv
sirna
cell
also
possibl
deliv
long
rna
dsrna
plasmid
viru
encod
short
hairpin
rna
shrna
longer
dsrna
shrna
molecul
cleav
enzym
call
dicer
short
sirna
sequenc
act
via
risc
howev
longer
rna
molecul
induc
cellular
immun
respons
via
interferon
system
major
obstacl
effect
employ
rnai
potenti
treat
diseas
correct
decreas
express
specif
protein
exampl
cancer
tissu
despit
enorm
potenti
use
sirna
yet
success
clinic
larg
due
difficulti
provid
effect
deliveri
sirna
desir
cell
similar
rna
molecul
sirna
highli
prone
degrad
ribonucleas
found
throughout
bodi
addit
rapidli
divid
cell
silenc
effect
sirna
provid
may
last
day
concentr
sirna
dilut
cell
furthermor
local
deliveri
sirna
specif
site
vivo
highli
fact
report
three
biggest
problem
rnai
therapeut
remain
deliveri
deliveri
field
gene
deliveri
signific
research
deliveri
plasmid
dna
howev
mani
result
necessarili
translat
deliveri
sirna
dna
sirna
differ
properti
dna
function
nucleu
sirna
activ
cytoplasm
rna
prone
degrad
nucleas
dna
hydroxyl
group
posit
due
small
size
approxim
nucleotid
length
sirna
stiffer
molecul
dna
behav
rigid
rod
may
condens
interact
cation
agent
deliveri
suggest
result
nanoparticl
becom
larg
endocytosi
provid
incomplet
differ
effect
deliveri
molecul
recent
review
gari
et
consid
deliveri
sirna
mani
diseas
state
system
effect
rnai
may
desir
exampl
includ
cancer
hiv
neurodegen
diseas
respiratori
virus
heart
vascular
diseas
howev
instanc
silenc
express
target
gene
throughout
bodi
could
detriment
local
area
need
treatment
exampl
includ
tumor
tumor
resect
site
also
possibl
aid
regener
diseas
damag
tissu
defect
site
concept
focu
local
deliveri
sirna
target
site
nake
sirna
deliveri
direct
inject
salin
excipi
solut
contain
sirna
sequenc
target
site
gener
nake
sirna
inject
bodi
short
half
life
order
minut
limit
howev
found
tissu
abl
uptak
nake
sirna
much
higher
degre
tissu
instanc
eye
central
nervou
system
lung
make
local
deliveri
direct
inject
sirna
site
possibl
one
largest
complic
lead
loss
sight
uncontrol
retin
neovascular
patient
ischem
retin
inhibit
vegf
antibodi
demonstr
reduc
ocular
neovascular
although
reduct
could
achiev
due
difficulti
deliv
antibodi
throughout
retin
thu
group
examin
direct
deliveri
eye
nake
sirna
target
vegf
reduc
neovascular
use
rna
interfer
ocular
neovascular
decreas
direct
inject
nake
sirna
vegf
retina
also
deliveri
sirna
target
vegf
receptor
result
decreas
ocular
neovascular
sirna
remain
present
cell
least
five
current
two
clinic
trial
underway
explor
deliveri
sirna
vegf
treat
macular
sever
report
local
deliveri
nake
sirna
nervou
system
intrathec
inject
nake
sirna
complementari
ion
channel
result
diminish
pain
silenc
peptid
direct
inject
sirna
hypothalamu
mice
led
decreas
bodi
weight
increas
metabol
could
impact
intracerebroventricular
inject
nake
sirna
also
shown
provid
gene
silenc
confin
brain
use
method
dopamin
serotonin
transport
silenc
affect
locomot
behavior
studi
also
demonstr
abil
deliv
nake
sirna
lung
typic
intranas
rout
heme
deliv
intranas
modul
cell
apoptosi
silenc
gene
shown
specif
intranas
deliveri
nake
sirna
target
genom
sever
acut
respiratori
syndrom
sar
coronaviru
deliv
either
infect
sar
viru
found
decreas
viru
level
lung
rhesu
macaqu
substanti
reduc
symptom
two
virus
infect
respiratori
system
vaccin
antivir
treatment
current
avail
includ
respiratori
syncyti
viru
rsv
parainfluenza
viru
rna
virus
encod
part
rna
polymeras
aid
replic
viral
genom
demonstr
intranas
deliveri
nake
sirna
target
subunit
viral
polymeras
abl
prevent
treat
virus
current
clinic
trial
underway
examin
efficaci
treatment
human
suffer
rsv
intratrach
instil
materi
introduc
directli
lung
via
cathet
needl
place
also
use
deliv
unmodifi
nake
sirna
lung
silenc
express
macrophag
inflammatori
protein
help
reduc
migrat
neutrophil
lung
acut
lung
effort
increas
activ
sirna
vivo
pursu
conjug
sirna
molecul
chemic
entiti
help
enhanc
cellular
uptak
sirna
andor
help
improv
pharmacokinet
variou
chemic
modif
sirna
review
frequent
lipophil
moieti
cholesterol
coval
bound
sirna
shown
provid
greater
vivo
stabil
associ
serum
protein
blood
therebi
prevent
plasma
clearanc
also
promot
increas
cell
uptak
due
increas
cell
membran
local
deliveri
use
chemic
modifi
sirna
focus
sirna
cholesterol
conjug
sirna
complementari
huntingtin
gene
found
patient
huntington
diseas
inject
directli
striatum
mice
found
local
silenc
gene
express
decreas
patholog
huntington
diseas
also
deliveri
sirna
target
herp
viral
protein
abl
protect
mice
herp
simplex
viru
sirna
appli
directli
vagin
addit
sirna
molecul
infus
directli
central
nervou
system
rat
uptaken
oligodendrocyt
cell
type
difficult
recent
studi
demonstr
modif
sirna
poli
ethylen
glycol
peg
either
galactos
effici
deliv
sirna
hepatocyt
previou
studi
demonstr
specif
uptak
intraven
inject
hepatocyt
vivo
similar
modif
use
antisens
oligonucleotid
although
demonstr
studi
hypothes
similar
result
obtain
modifi
sirna
increas
sirna
vivo
encapsul
within
liposom
complex
cation
lipid
form
nanoparticl
liposom
typic
consist
phospholipid
bilay
surround
aqueou
core
within
core
sirna
nucleotid
protein
drug
contain
recent
liposom
contain
sirna
modifi
peptid
target
breast
cancer
cell
shown
effect
silenc
express
gene
play
role
breast
cancer
carcinogenesi
minim
uptak
silenc
effect
popular
altern
liposom
use
lipoplex
cation
lipid
mix
anion
sirna
form
complex
base
electrostat
interact
howev
complex
tend
unstabl
solut
may
aggreg
addit
due
charg
cytotox
induc
inflammatori
complex
red
fluoresc
protein
rfp
cation
lipid
demonstr
silenc
express
rfp
inject
local
tumor
express
rfp
form
anoth
group
demonstr
uptak
sirna
subcutan
tumor
sirna
complex
cholesterol
deriv
cholesteryl
inject
local
sirna
incorpor
lipoplex
also
found
uptaken
high
effici
vagin
mucosa
directli
appli
area
shown
effect
silenc
express
herp
viral
protein
protect
mice
infect
herp
simplex
viru
sirna
lamin
ac
incorpor
lipoplex
local
silenc
found
vagin
addit
group
demonstr
local
deliveri
sirna
lipoplex
colon
anoth
mucos
surfac
silenc
express
colon
inflamm
reduc
mice
inflammatori
bowel
deliveri
sirna
hepat
tissu
rodent
primat
demonstr
use
modif
lipid
hepat
gene
transthyretin
target
primat
use
formul
highest
concentr
sirna
mg
approxim
reduct
gene
express
observ
h
intraven
deliveri
interest
approach
local
deliveri
sirna
involv
synthesi
oleic
liposom
magnet
core
compris
colloid
suspens
magnet
nanocryst
sirna
abl
interact
liposom
electrostat
interact
sirna
oleic
acid
thu
essenti
form
lipoplex
magnet
liposom
particl
carri
sirna
target
epiderm
growth
factor
receptor
inject
intraven
allow
travel
system
mice
found
accumul
high
amount
local
tumor
extern
magnet
field
particl
howev
still
made
way
tissu
includ
lung
liver
spleen
frequent
cation
polym
use
form
nanoscal
sirna
complex
base
electrostat
interact
neg
charg
sirna
posit
charg
polym
poli
ethyleneimin
pei
one
polym
pei
synthet
polym
either
linear
branch
high
percentag
free
amin
group
posit
charg
pei
complex
sirna
target
vegf
inject
directli
subcutan
tumor
silenc
vegf
subsequ
diminish
tumor
growth
also
deliv
intratumor
sirna
complementari
promot
apoptosi
tumor
cell
result
reduc
tumor
weight
size
mice
increas
circul
time
particl
pei
modifi
peg
hydrophil
molecul
adsorb
serum
protein
drawback
ad
peg
pei
reduc
posit
charg
polym
thu
lessen
interact
cell
membran
lead
decreas
uptak
pei
particl
sirna
complex
success
deliv
tracheal
intub
lung
major
particl
end
lung
gene
silenc
although
sirna
complex
found
chitosan
natur
polysaccharid
deriv
shell
crustacean
anoth
polyc
use
sirna
complex
nanocomplex
sirna
target
enhanc
green
fluoresc
protein
egfp
deliv
lung
egfp
transgen
mice
nasal
administr
shown
silenc
egfp
express
approxim
six
day
deliv
daili
per
chitosan
complex
sirna
red
fluoresc
protein
rfp
deliv
intratumor
subcutan
tumor
express
rfp
shown
reduc
rfp
express
approxim
thioket
nanoparticl
demonstr
protect
sirna
deliv
oral
reach
intestin
tract
effect
uptaken
nanoparticl
formul
polym
poli
dimethylen
thioket
degrad
respons
high
level
reactiv
oxygen
speci
found
site
intestin
inflamm
use
nanoparticl
silenc
colon
shown
protect
mice
ulcer
coliti
nanoparticl
also
modifi
target
ligand
increas
uptak
desir
cell
popul
even
formul
deliv
system
instanc
egfr
nanogel
compos
primarili
conjug
peptid
target
although
yet
test
vivo
silenc
egfr
seen
cell
line
express
receptor
silenc
found
cell
line
express
receptor
poli
propyleneimin
ppi
dendrim
also
use
creat
nanoparticl
particl
modifi
synthet
analogu
lutein
hormon
lhrh
peptid
increas
uptak
cancer
cell
overexpress
lhrh
group
demonstr
sirna
particl
inde
uptaken
much
higher
degre
vivo
tumor
cell
notabl
recent
clinic
trial
examin
deliveri
polymer
nanoparticl
modifi
target
ligand
human
transferrin
protein
receptor
upregul
tumor
human
although
nanoparticl
deliv
system
found
local
solid
tumor
patient
sirna
target
subunit
ribonucleotid
reductas
establish
target
mrna
protein
level
tumor
biopsi
found
reduc
system
promis
target
treatment
solid
tumor
altern
smart
nanoparticl
design
releas
payload
receiv
physic
signal
one
exampl
use
gold
nanospher
thiolat
sirna
complementari
gold
nanoparticl
expos
light
absorb
light
experi
chang
shape
releas
sirna
thu
nanoparticl
uptaken
cell
particl
cell
expos
light
penetr
deep
tissu
releas
sirna
cytoplasm
group
demonstr
target
knockdown
tumor
tissu
increas
suscept
tumor
chemotherapeut
drug
polymer
microparticl
also
use
deliveri
sirna
although
report
poli
acid
plga
biodegrad
synthet
polym
use
encapsul
sirna
plga
microspher
mm
diamet
microspher
inject
adjac
subcutan
tumor
result
decreas
tumor
growth
cours
three
describ
section
mani
current
technolog
examin
sirna
deliveri
reli
format
nanoscal
sirna
complex
case
microscal
complex
major
disadvantag
use
techniqu
local
deliveri
rapidli
dispers
deliveri
site
due
small
size
therefor
challeng
get
suffici
amount
sirna
desir
locat
desir
period
time
still
remain
pauciti
work
examin
use
macroscop
biomateri
scaffold
local
deliveri
sirna
biomateri
scaffold
frequent
use
tissu
engin
encourag
cell
migrat
prolifer
within
materi
place
tissu
defect
site
often
possibl
incorpor
bioactiv
factor
scaffold
encourag
tissu
regener
process
factor
releas
scaffold
time
incorpor
cell
surround
host
cell
although
tradit
bioactiv
factor
growth
factor
dna
upregul
express
growth
transcript
factor
may
benefici
use
sirna
aid
tissu
regener
process
perhap
inhibit
product
molecul
hinder
heal
process
influenc
cell
behavior
prolifer
differenti
use
rna
interfer
regen
medicin
applic
review
yao
et
releas
sirna
incorpor
biomateri
scaffold
could
mediat
diffus
biopolym
pore
degrad
polym
ionic
affin
interact
scaffold
releas
sirna
would
act
local
scaffold
could
aid
tissu
regener
provid
conduct
induct
environ
cellular
growth
within
work
laboratori
first
demonstr
potenti
ionic
crosslink
algin
photocrosslink
algin
collagen
hydrogel
shown
provid
vari
sirna
releas
profil
case
sirna
releas
bioactiv
abl
silenc
protein
express
cell
surround
scaffold
incorpor
within
scaffold
schemat
shown
figur
use
collagen
scaffold
deliv
nanoparticl
also
recent
demonstr
although
found
approxim
sirna
releas
first
two
day
littl
subsequ
howev
nanoparticl
deliv
scaffold
shown
reduc
protein
express
seven
day
cell
cultur
directli
scaffold
singh
et
al
incorpor
dna
sirna
chemokin
plga
microparticl
incorpor
hydrogel
made
either
dextran
vinyl
sulfon
poli
ethylen
glycol
peg
peg
chemokin
releas
hydrogel
promot
migrat
cell
hydrogel
cell
abl
uptak
sirna
dna
releas
plga
microparticl
develop
biomateri
scaffold
system
other
incorpor
sirna
offer
excit
possibl
sustain
target
deliveri
sirna
specif
site
vivo
rna
interfer
offer
great
promis
treat
variou
diseas
state
help
repair
damag
tissu
howev
signific
challeng
need
overcom
technolog
use
clinic
set
particular
applic
benefit
local
deliveri
sirna
import
develop
system
capabl
provid
bioactiv
sirna
specif
site
rather
system
highlight
articl
mani
group
examin
local
deliveri
sirna
use
variou
deliveri
modal
tabl
certain
tissu
demonstr
simpl
inject
nake
sirna
silenc
gene
express
specif
tissu
howev
techniqu
local
deliveri
unfortun
limit
tissu
type
includ
eye
central
nervou
system
lung
achiev
local
gene
silenc
tissu
varieti
approach
pursu
help
stabil
sirna
encourag
cellular
uptak
administr
site
interest
includ
chemic
modif
sirna
complex
within
liposom
polym
form
nanoparticl
overal
field
sirna
deliveri
focus
use
nanoparticl
may
promot
stabil
uptak
sirna
necessarili
provid
local
may
readili
carri
away
site
interest
recent
use
macroscop
biomateri
scaffold
sirna
deliveri
examin
report
still
signific
work
done
area
optim
deliveri
system
ensur
releas
bioactiv
sirna
site
interest
howev
import
area
research
warrant
studi
offer
potenti
great
impact
field
sirna
deliveri
